Buyout buzz: Royalty might mount joint effort to acquire Elan

Ryan McBride

In the latest twist in Pharma's plot to buy , the business press has caught wind that Royalty may decide to revive its pursuit of with the help and financial support of a partner. This scenario involves multiple factors, including 's willingness to take offers from bidders, and none of the players is commenting on the record about the situation.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS